A study suggests that chemotherapy drugs may activate AF-related genes (44), such as docetaxel activating ANXA5 (one of the most abundant membrane-associated proteins in cardiomyocytes), thereby increasing the risk of AF. Here, ANXA5 is linked to atrial fibrillation.